The invention is concerned with novel imidazopyrimidine derivatives of formula (I)
wherein R
1
, R
2
and R
8
are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit PDE10A and can be used as pharmaceuticals.
Escaping from Flatland: Antimalarial Activity of sp<sup>3</sup>-Rich Bridged Pyrrolidine Derivatives
作者:Brian Cox、James Duffy、Victor Zdorichenko、Corentin Bellanger、Jessica Hurcum、Benoît Laleu、Kevin I. Booker-Milburn、Luke D. Elliott、Michael Robertson-Ralph、Christopher J. Swain、Stephen J. Bishop、Irene Hallyburton、Mark Anderson
DOI:10.1021/acsmedchemlett.0c00486
日期:2020.12.10
We utilized synthetic photochemistry to generate novel sp3-rich scaffolds and report the design, synthesis, and biological testing of a diverse series of amides based on the 1-(amino-methyl)-2-benzyl-2-aza-bicyclo[2.1.1]hexane scaffold. Preliminary antimalarial screening of the library provided promising compounds with activity in the 1–5 μM range with an enhanced hit rate. Further evaluation (solubility
BENZPYRAZOL DERIVATIVES AS INHIBITORS OF PI3 KINASES
申请人:Baldwin Ian Robert
公开号:US20110178063A1
公开(公告)日:2011-07-21
The invention is directed to certain novel compounds of formula (I) and salts thereof. The compounds of the invention are inhibitors of PI3-kinase activity.
Benzpyrazol derivatives as inhibitors of PI3 kinases
申请人:Baldwin Ian Robert
公开号:US08658635B2
公开(公告)日:2014-02-25
The invention is directed to certain novel compounds of formula (I) and salts thereof. The compounds of the invention are inhibitors of PI3-kinase activity.